High-Yield Executive Summary Multimodal treatment combining advanced imaging, molecular diagnostics, and limb-sparing surgery has redefined bone tumor management, improving survival and function. Accurate classification using Enneking and AJCC staging systems guides surgical margins and adjuvant therapy decisions. Neoadjuvant chemotherapy and targeted agents have expanded indications for limb salvage, reducing amputation rates. Innovations in 3D printing […]
Managing Pathologic Fractures: An Informative Guide for Orthopaedic Residents, Fellows, and Surgical Learners High-Yield Executive Summary Pathologic fractures occur through bone weakened by underlying disease, most commonly metastatic cancer, requiring tailored management distinct from traumatic fractures. Accurate classification of the lesion (lytic, blastic, or mixed) and fracture stability assessment are critical to guide surgical versus […]
High-Yield Executive Summary Persistent pain, especially nocturnal and unrelated to activity, is a critical clinical red flag for malignancy in a bone lesion. Radiographic features such as poorly defined margins, cortical destruction, periosteal reaction, and soft tissue mass strongly suggest malignancy. Systemic symptoms (weight loss, fever, night sweats) and elevated inflammatory markers warrant urgent oncologic […]
What Are The Treatment Options for Metastatic Bone Disease? The “High-Yield” Executive Summary Metastatic bone disease (MBD) primarily requires a multidisciplinary approach balancing systemic oncologic control with local skeletal stabilization to maintain function and quality of life. Surgical intervention is indicated for impending or actual pathological fractures, intractable pain refractory to radiation, or spinal cord […]
High-Yield Executive Summary Metastatic bone disease (MBD) from thyroid cancer, particularly differentiated thyroid carcinoma (DTC), often presents with osteolytic lesions that predispose to pathological fractures and significant morbidity. Prognosis depends heavily on histologic subtype, extent of systemic disease, and response to radioactive iodine (RAI) therapy; surgical intervention aims to restore function and palliate symptoms rather […]
High-Yield Executive Summary Metastatic bone disease (MBD) primarily affects the axial and proximal appendicular skeleton, with the femur, humerus, and spine being the most common sites requiring surgical intervention. Surgical treatment aims to restore mechanical stability, alleviate pain, and preserve function; implant choice depends on lesion location, expected survival, and tumor biology. Mirels’ scoring system […]
Principles of Surgical Margins in the Resection of Bone Tumors High-Yield Executive Summary Surgical margin status is the single most critical factor influencing local tumor control and overall survival in bone tumor resections. Achieving a wide or radical margin reduces recurrence risk. Margin classification (intralesional, marginal, wide, radical) directly guides adjuvant therapy and reconstructive strategy. […]
High-Yield Executive Summary Multidisciplinary coordination is essential for optimizing outcomes in bone tumor patients, involving orthopaedic oncologists, radiologists, pathologists, medical and radiation oncologists, and rehabilitation specialists. Accurate diagnosis and staging using advanced imaging and biopsy techniques directly influence surgical planning and adjuvant therapy decisions. Surgical management prioritizes oncologic clearance with limb salvage when feasible, balancing […]
High-Yield Executive Summary Radiation therapy (RT) is primarily indicated for inoperable primary bone tumors, metastatic bone disease, and adjuvant treatment in select sarcomas to improve local control. RT is critical in palliation of pain and prevention of pathological fractures in metastatic bone lesions when surgery is contraindicated or as an adjunct. The decision to use […]
High-Yield Executive Summary Multimodal treatment is standard: Surgical resection with negative margins remains the cornerstone, often combined with radiation and/or chemotherapy based on histologic subtype and grade. Anatomic compartment and tumor grade dictate approach: Limb-sparing surgery is preferred when feasible; amputation is reserved for unresectable or recurrent disease. Preoperative imaging and biopsy are critical: MRI […]
Last Updated on January 25, 2026 by Christian Veillette
